<?xml version='1.0' encoding='utf-8'?>
<document id="28105513"><sentence text="Pharmacokinetics of ginkgolides A, B and K after single and multiple intravenous infusions and their interactions with midazolam in healthy Chinese male subjects."><entity charOffset="20-33" id="DDI-PubMed.28105513.s1.e0" text="ginkgolides A" /><entity charOffset="119-128" id="DDI-PubMed.28105513.s1.e1" text="midazolam" /><pair ddi="false" e1="DDI-PubMed.28105513.s1.e0" e2="DDI-PubMed.28105513.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s1.e0" e2="DDI-PubMed.28105513.s1.e1" /></sentence><sentence text="Ginkgo terpene lactones meglumine injection (GMI) is a novel preparation of traditional Chinese medicine that contains ginkgolides A, B and K (GA, GB, GK, respectively) as its primary components"><entity charOffset="7-33" id="DDI-PubMed.28105513.s2.e0" text="terpene lactones meglumine" /><entity charOffset="119-132" id="DDI-PubMed.28105513.s2.e1" text="ginkgolides A" /><entity charOffset="143-145" id="DDI-PubMed.28105513.s2.e2" text="GA" /><entity charOffset="147-149" id="DDI-PubMed.28105513.s2.e3" text="GB" /><entity charOffset="151-153" id="DDI-PubMed.28105513.s2.e4" text="GK" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e0" e2="DDI-PubMed.28105513.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e0" e2="DDI-PubMed.28105513.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e0" e2="DDI-PubMed.28105513.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e0" e2="DDI-PubMed.28105513.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e0" e2="DDI-PubMed.28105513.s2.e4" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e1" e2="DDI-PubMed.28105513.s2.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e1" e2="DDI-PubMed.28105513.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e1" e2="DDI-PubMed.28105513.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e1" e2="DDI-PubMed.28105513.s2.e4" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e2" e2="DDI-PubMed.28105513.s2.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e2" e2="DDI-PubMed.28105513.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e2" e2="DDI-PubMed.28105513.s2.e4" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e3" e2="DDI-PubMed.28105513.s2.e3" /><pair ddi="false" e1="DDI-PubMed.28105513.s2.e3" e2="DDI-PubMed.28105513.s2.e4" /></sentence><sentence text=" In this study we evaluated the safety, tolerability and pharmacokinetics of these three ginkgolides after single and multiple intravenous infusions of GMI"><entity charOffset="89-100" id="DDI-PubMed.28105513.s3.e0" text="ginkgolides" /></sentence><sentence text=" We also investigated the effect of GMI on cytochrome P450 3A4 (CYP3A4) in healthy Chinese volunteers" /><sentence text="" /><sentence text="In this open-label, placebo-controlled study 15 subjects were randomly assigned to receive GMI or matched placebo (4:1 ratio)" /><sentence text=" All subjects first received midazolam (MDZ) on day 1, followed by a 6-day washout"><entity charOffset="29-38" id="DDI-PubMed.28105513.s7.e0" text="midazolam" /><entity charOffset="40-43" id="DDI-PubMed.28105513.s7.e1" text="MDZ" /><pair ddi="false" e1="DDI-PubMed.28105513.s7.e0" e2="DDI-PubMed.28105513.s7.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s7.e0" e2="DDI-PubMed.28105513.s7.e1" /></sentence><sentence text=" On Day 8, the subjects were started on once-daily dosing of either GMI or placebo for 14 days" /><sentence text=" Lastly, on Day 22 the subjects were given second dose of MDZ + GMI or MDZ + placebo"><entity charOffset="58-60" id="DDI-PubMed.28105513.s9.e0" text="MDZ" /><entity charOffset="71-73" id="DDI-PubMed.28105513.s9.e1" text="MDZ" /><pair ddi="false" e1="DDI-PubMed.28105513.s9.e0" e2="DDI-PubMed.28105513.s9.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s9.e0" e2="DDI-PubMed.28105513.s9.e1" /></sentence><sentence text=" Plasma concentrations of ginkgolides, MDZ and its metabolite 1-hydroxy midazolam were quantified"><entity charOffset="26-37" id="DDI-PubMed.28105513.s10.e0" text="ginkgolides" /><entity charOffset="39-42" id="DDI-PubMed.28105513.s10.e1" text="MDZ" /><entity charOffset="62-81" id="DDI-PubMed.28105513.s10.e2" text="1-hydroxy midazolam" /><pair ddi="false" e1="DDI-PubMed.28105513.s10.e0" e2="DDI-PubMed.28105513.s10.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s10.e0" e2="DDI-PubMed.28105513.s10.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s10.e0" e2="DDI-PubMed.28105513.s10.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s10.e1" e2="DDI-PubMed.28105513.s10.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s10.e1" e2="DDI-PubMed.28105513.s10.e2" /></sentence><sentence text="" /><sentence text="The steady-state conditions of GA, GB and GK were achieved after 6 days of daily dosing"><entity charOffset="31-33" id="DDI-PubMed.28105513.s12.e0" text="GA" /><entity charOffset="35-36" id="DDI-PubMed.28105513.s12.e1" text="GB" /><entity charOffset="42-43" id="DDI-PubMed.28105513.s12.e2" text="GK" /><pair ddi="false" e1="DDI-PubMed.28105513.s12.e0" e2="DDI-PubMed.28105513.s12.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s12.e0" e2="DDI-PubMed.28105513.s12.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s12.e0" e2="DDI-PubMed.28105513.s12.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s12.e1" e2="DDI-PubMed.28105513.s12.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s12.e1" e2="DDI-PubMed.28105513.s12.e2" /></sentence><sentence text=" Following a single dose of GMI (Day 8) the area under the concentration-timecurve from zero to 24 h after administration (AUC0-24h) of GA, GB and GK (arithmetic ± standard deviation) was 4"><entity charOffset="136-137" id="DDI-PubMed.28105513.s13.e0" text="GA" /><entity charOffset="140-141" id="DDI-PubMed.28105513.s13.e1" text="GB" /><entity charOffset="147-148" id="DDI-PubMed.28105513.s13.e2" text="GK" /><pair ddi="false" e1="DDI-PubMed.28105513.s13.e0" e2="DDI-PubMed.28105513.s13.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s13.e0" e2="DDI-PubMed.28105513.s13.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s13.e0" e2="DDI-PubMed.28105513.s13.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s13.e1" e2="DDI-PubMed.28105513.s13.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s13.e1" e2="DDI-PubMed.28105513.s13.e2" /></sentence><sentence text="10 ± 1" /><sentence text="06, 4" /><sentence text="61 ± 1" /><sentence text="31 and 0" /><sentence text="127 ± 0" /><sentence text="102 h μg/mL, respectively; the corresponding values following multiple doses of GMI (Day 19) were 3" /><sentence text="94 ± 1" /><sentence text="16, 5" /><sentence text="00 ± 1" /><sentence text="55 and 0" /><sentence text="118 ± 0" /><sentence text="096 h μg/mL, respectively" /><sentence text=" The mean accumulation ratios were 0" /><sentence text="95, 1" /><sentence text="08 and 0" /><sentence text="89 for GA, GB and GK, respectively"><entity charOffset="7-8" id="DDI-PubMed.28105513.s29.e0" text="GA" /><entity charOffset="11-12" id="DDI-PubMed.28105513.s29.e1" text="GB" /><entity charOffset="18-19" id="DDI-PubMed.28105513.s29.e2" text="GK" /><pair ddi="false" e1="DDI-PubMed.28105513.s29.e0" e2="DDI-PubMed.28105513.s29.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s29.e0" e2="DDI-PubMed.28105513.s29.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s29.e0" e2="DDI-PubMed.28105513.s29.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s29.e1" e2="DDI-PubMed.28105513.s29.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s29.e1" e2="DDI-PubMed.28105513.s29.e2" /></sentence><sentence text=" Additionally, the geometric mean [peak concentration (Cmax) and AUC0-24h] ratios of MDZ and 1-hydroxy midazolam were all within the specified acceptance ranges in the MDZ + placebo treatment and MDZ + GMI treatment"><entity charOffset="93-112" id="DDI-PubMed.28105513.s30.e0" text="1-hydroxy midazolam" /><entity charOffset="85-103" id="DDI-PubMed.28105513.s30.e1" text="MDZ" /><entity charOffset="168-186" id="DDI-PubMed.28105513.s30.e2" text="MDZ" /><entity charOffset="196-214" id="DDI-PubMed.28105513.s30.e3" text="MDZ" /><pair ddi="false" e1="DDI-PubMed.28105513.s30.e1" e2="DDI-PubMed.28105513.s30.e1" /><pair ddi="false" e1="DDI-PubMed.28105513.s30.e1" e2="DDI-PubMed.28105513.s30.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s30.e1" e2="DDI-PubMed.28105513.s30.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s30.e1" e2="DDI-PubMed.28105513.s30.e3" /><pair ddi="false" e1="DDI-PubMed.28105513.s30.e0" e2="DDI-PubMed.28105513.s30.e0" /><pair ddi="false" e1="DDI-PubMed.28105513.s30.e0" e2="DDI-PubMed.28105513.s30.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s30.e0" e2="DDI-PubMed.28105513.s30.e3" /><pair ddi="false" e1="DDI-PubMed.28105513.s30.e2" e2="DDI-PubMed.28105513.s30.e2" /><pair ddi="false" e1="DDI-PubMed.28105513.s30.e2" e2="DDI-PubMed.28105513.s30.e3" /></sentence><sentence text="" /><sentence text="Our results show that GMI was well tolerated during the entire study" /><sentence text=" There was no systemic accumulation and no significant effects on the pharmacokinetics of MDZ in healthy Chinese male subjects after repeated dosing of GMI"><entity charOffset="90-92" id="DDI-PubMed.28105513.s33.e0" text="MDZ" /></sentence><sentence text="" /></document>